Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors
Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.17.6644
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2009
Authors
Publisher
American Society of Clinical Oncology (ASCO)